HMZS Biopharmaceutical

Policy / Regulatory

HMZS Biopharmaceutical Blacklisted After Failing to Monitor Production Process

Fineline Cube Mar 18, 2025

HMZS Biopharmaceutical, a Chinese company that won a bid for its phloroglucinol in the 10th...

Company Drug

Sino Biopharm’s TQA3605 Meets Endpoint in Hepatitis B Phase II Trial

Company Drug

J&J Darzalex Faspro Gets FDA Nod for NDMM D-VRd Regimen

Company Drug

Roche CT-388 Obesity Drug Shows 22.5% Weight Loss in Phase II Trial

Policy / Regulatory

FDA Removes Suicide Warnings from GLP‑1 Drugs After Investigation Finds No Causal Link